ZT-12-037-01 is utilized in pharmaceutical research and development, particularly for treating neurological and brain-related disorders such as psychiatric conditions and neurodegenerative diseases. It demonstrates potential in enhancing neuronal cell function and reducing brain inflammation. Preliminary studies also indicate its role in inhibiting the growth of certain cancer cells, positioning it as a candidate for future anti-cancer drug development.